Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation

British Journal of Cancer

Volumn 100, Issue 3, 2009, Pages 501-510

  Rahman, M M ^a   Qian, Z R ^a   Wang, E L ^a   Sultana, R ^a   Kudo, E ^a   Nakasono, M ^a   Hayashi, T ^b   Kakiuchi, S ^a   Sano, T ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

GEP NETs; HMGA1; HMGA2; let 7

Indexed keywords

HIGH MOBILITY GROUP A1A PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; KI 67 ANTIGEN; LET 7 PROTEIN; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

DIGESTIVE SYSTEM NEOPLASMS; DOWN-REGULATION; HMGA PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; NEUROENDOCRINE TUMORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 59649121124     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604883     Document Type: Article

References (36)

1. Brenner B, Tang LH, Klimstra DS, Kelsen DP (2004) Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol 22: 2730-2739
2. Caldas C, Brenton JD (2005) Sizing up miRNAs as cancer genes. Nat Med 11: 712-714
3. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, Simeone A, Fusco A (1996) High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13: 2439-2446
4. Delle Fave G, Corleto VD (2001) Oncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal. Ann Oncol 2S: 13-17
5. Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269
6. Fusco A, Fedele M (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7: 899-910
7. Gustafsson BI, Kidd M, Modlin IM (2008) Neuroendocrine tumours of the diffuse neuroendocrine system. Curr Opin Oncol 20: 1-12
8. Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ (2007) High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 6: 5
9. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070
10. Ito T, Tanaka M, Sasano H, Osamura YR, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Imamura M, Kawabe K, Nakamura K, Neuroendocrine Tumour Workshop of Japan (2007) Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumours. J Gastroenterol 42: 497-500
11. Johnson KR, Lehn DA, Reeves R (1989) Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMGI and HMG-Y. Mol Cell Biol 9: 2114-2123
12. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647
13. Klöppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumours: the WHO classification. Ann N Y Acad Sci 1014: 13-27
14. Lee YS, Dutta A (2007) The tumour suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030
15. Liau SS, Jazag A, Whang EE (2006) HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma. Cancer Res 66: 11613-11622
16. Lubensky IA, Zhuang Z (2007) Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumours. Endocr Pethol 18: 156-162
17. Maggard MA, O'Connell JB, Ko CY (2004) Updated population-based review of carcinoid tumours. Ann Surg 240: 117-122
18. Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579
19. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M (2008) Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 14: 2334-2340
20. Oberg K (2002) Carcinoid tumours: molecular genetics, tumour biology, and update of diagnosis and treatment. Curr Opin Oncol 14: 38-45
21. Qian ZR, Sano T, Yoshimoto K, Yamada S, Ishizuka A, Mizusawa N, Horiguchi H, Hirokawa M, Asa SL (2005) Inactivation of RASSF1A tumour suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas. Lab Invest 85: 464-743
22. Reeves R (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277: 63-81
23. Reeves R, Nissen MS (1990) The AT DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 265: 8573-8582
24. Rindi G, Bordi C (2005) Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics. Best Pract Res Clin Gastroenterol 19: 519-534
25. Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B, all other Frascati Consensus Conference participants; European Neuroendocrine Tumoursociety (ENETS) (2006) TNM staging of foregut (neuro)endocrine tumours: a consensus proposal including a grading system. Virchows Arch 449: 395-401
26. Rindi G, Klöppel G, Couvelard A, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B (2007) TNM staging of midgut and hindgut (neuro) endocrine tumours: a consensus proposal including a grading system. Virchows Arch 451: 757-762
27. Sarhadi VK, Wikman H, Salmenkivi K, Kuosma E, Sioris T, Salo J, Karjalainen A, Knuutila S, Anttila S (2006) Increased expression of high mobility group A proteins in lung cancer. J Pathol 209: 206-212
28. Scala S, Portella G, Fedele M, Chiappetta G, Fusco A (2000) Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci USA 97: 4256-4261
29. Sgarra R, Rustighi A, Tessari MA, Di Bernardo J, Altamura S, Fusco A, Manfioletti G, Giancotti V (2004) Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett 574: 1-8
30. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E, Peter ME (2007) Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104: 11400-11405
31. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756
32. Thanos D, Du W, Maniatis T (1993) The high mobility group protein HMG I(Y) is an essential structural component of a virus-inducible enhancer complex. Cold Spring Harb Symp Quant Biol 58: 73-81
33. Thanos D, Maniatis T (1992) The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 27: 777-789
34. Wang T, Zhang X, Obijuru L, Laser J, Aris V, Lee P, Mittal K, Soteropoulos P, Wei JJ (2007) A micro-RNA signature associated with race, tumoursize, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer 46: 336-347
35. Zhou X, Benson KF, Ashar HR, Chada K (1995) Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376: 771-774
36. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM (2005) The molecular genetics of gastroenteropancreatic neuroendocrine tumours. Cancer 104: 2292-2309